Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis
Authors:
- 8 May 2012
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 19 (9) , 1251-1255
Abstract
Background and purpose To test whether time to recanalization is associated with a progressive risk of symptomatic intracerebral haemorrhage (SICH) after intravenous alteplase (IVT), we conducted a serial transcranial duplex monitoring study up to 24 h after IVT in a cohort of 140 patients with acute ischaemic stroke attributed to large artery occlusion in the anterior circulation. Methods Patients were classified in four groups according to the time to complete recanalization (Thrombolysis in Brain Ischaemia, TIBI grades 4 or 5) after alteplase bolus: n = 53), 2–6 h (n = 9), 6–24 h (n = 32) and no recanalization (NR) at 24 h (n = 46). SICH was defined as any haemorrhagic transformation with National Institute of Health Stroke Scale (NIHSS) score worsening ≥4 points (European Australian Acute Stroke Study II, ECASS II criteria) or parenchymal haematoma type 2 with neurological worsening (SITS-MOST criteria) in the 24–36 h CT. Favourable outcome was defined as modified Rankin score ≤2 at 3 months. Results There were no differences between the groups of patients who recanalized at each time frame regarding localization of the occlusion ( P = 0.29), stroke severity at baseline ( P = 0.22) and age ( P = 0.06). SICH (ECASS/SITS-MOST) was observed in 5.7%/5.7% of the patients who recanalized in P < 0.001). Conclusions Our findings are in line with the literature showing a relationship between time to recanalization and functional outcome after IVT in acute stroke, but they do not confirm a progressive increase in the rate of SICH.Keywords
This publication has 22 references indexed in Scilit:
- A Mouse Model of Hemorrhagic Transformation by Delayed Tissue Plasminogen Activator Administration After In Situ Thromboembolic StrokeStroke, 2011
- Thrombolysis at 3–4.5 Hours after Acute Ischemic Stroke Onset – Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) RegistryCerebrovascular Diseases, 2010
- Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTRThe Lancet Neurology, 2010
- Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsThe Lancet, 2010
- Symptomatic intracerebral hemorrhage and recanalization after IV rt-PANeurology, 2008
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- Temporal Profile of Recanalization After Intravenous Tissue Plasminogen ActivatorStroke, 2006
- Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic StrokeStroke, 2006
- Thrombolysis-Related Hemorrhagic InfarctionStroke, 2002
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995